logo

For the Inventor, By the Inventor

New South Wales, Australia

Vectus Biosystems Limited

Calculating rank
USPTO Granted Patents = 15

% Expired Patents = 13.3



Forward Citations = 27

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Karen Annette Duggan (13 out of 17 patents)

silverMedal Anthony Kaye (2 out of 2 patents)

bronzeMedal Nurul Quazi (2 out of 10 patents)

4.  George Feast (2 out of 2 patents)

5.  Marshnil Lakshman (2 out of 2 patents)


15 patents:

1. 11834417 - Compositions for the treatment of hypertension and/or fibrosis (2023-12-05),
2. 11401245 - Compositions for the treatment of pulmonary fibrosis (2022-08-02),
3. 11401235 - Synthesis of terphenyl compounds (2022-08-02),
4. 11053202 - Compositions for the treatment of hypertension and/or fibrosis (2021-07-06),
5. 10919863 - Compositions for the treatment of pulmonary fibrosis (2021-02-16),
6. 10752578 - Synthesis of terphenyl compounds (2020-08-25),
7. 10183908 - Compositions for the treatment of kidney and/or liver disease (2019-01-22),
8. 10035775 - Compositions for the treatment of fibrosis and fibrosis-related conditions (2018-07-31),
9. 9732136 - VIP fragments and methods of use (2017-08-15),
10. 9630935 - Compositions for the treatment of hypertension and/or fibrosis (2017-04-25),
11. 9458093 - Compositions for the treatment of hypertension and/or fibrosis (2016-10-04),
12. 9340583 - VIP fragments and methods of use (2016-05-17),
13. 8916523 - VIP fragments and methods of use (2014-12-23),
14. 8470778 - VIP fragments and methods of use (2013-06-25),
15. 7951777 - Compositions and methods for treatment of cardiovascular disease (2011-05-31),
Company Overview
Vectus Biosystems Limited is a biotechnology company based in New South Wales, Australia, specializing in the development of innovative therapies for various medical conditions. The organization focuses on harnessing advanced biopharmaceutical technologies to create solutions that address unmet medical needs. With a commitment to research and development, Vectus aims to improve patient outcomes through its cutting-edge approaches in drug formulation and delivery systems, positioning itself as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

15 Patents

#13 in New South Wales

#246 in Australia

#39,991 in the World

New South Wales, AU
New South Wales, Australia

Vectus Biosystems Limited

Forward Citations = 27

5 inventors:

goldMedal Karen Annette Duggan (13 out of 17 patents)

silverMedal Anthony Kaye (2 out of 2 patents)

bronzeMedal Nurul Quazi (2 out of 10 patents)

4.  George Feast (2 out of 2 patents)

5.  Marshnil Lakshman (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vectus Biosystems Limited. Retrieved from https://idiyas.com/company/vectus-biosystems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…